3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Mesothelioma, Malignant
4
Urethral Neoplasms
3
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solitary Fibrous Tumor, Pleural
1
Sertoli-Leydig Cell Tumor
1
Interventions
Ifosfamide
11
Methotrexate
9
Doxorubicin
7
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Cisplatin
6
Leucovorin
5
Etoposide
5
X-Rays
4
Specimen Handling
4
Sirolimus
4
Phantoms, Imaging
4
Gemcitabine
4
temsirolimus
3
sargramostim
3
dinutuximab
3
cixutumumab
3
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Dexrazoxane
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
samarium Sm-153 lexidronam
2
palbociclib
2
olaparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Osteosarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts